TrialOpen heart2026

Racial outcomes in patients with diabetic cardiomyopathy treated with an aldose reductase inhibitor: the ARISE-HF trial.

Jose L Batista et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.